jueves, 10 de septiembre de 2026
U.K. unveils recommendations for regulating AI in medicine Authorities worldwide, including in U.S., are trying to balance tech’s potential and risks
https://www.statnews.com/2026/09/09/uk-unveils-recommendations-ai-regulation-medicine/
By Andrew JosephSept. 9, 2026
Europe Correspondent
Health regulators are scrambling to stay on top of AI
As health systems race toward increasingly autonomous AI, regulators are trying to figure out how to oversee technology that might change after it reaches patients. A U.K. commission issued 44 recommendations for regulating medical AI, STAT’s Andrew Joseph writes, which include staged approvals and continuous monitoring of products in clinical use. It also gives U.K. regulators stronger enforcement power.
Meanwhile, the U.S. government will test this idea in the real world: ARPA-H plans to commit up to $62.7 million to develop AI agents that could help manage heart failure, STAT’s Mario Aguilar writes. The idea is that the agents could eventually assess symptoms, order labs, or even prescribe medications with limited clinician involvement. This will be tested in a randomized trial of 2,000 to 3,000 patients at Kaiser Permanente.
https://www.statnews.com/2026/09/09/uk-unveils-recommendations-ai-regulation-medicine/
Read more about the U.K. here.
And about the ARPA-H program here.
https://www.statnews.com/2026/09/09/arpa-h-advocate-program-autonomous-ai-bots-for-heart-failure/?utm_campaign=the_readout&utm_medium=email&_hsenc=p2ANqtz-9t4GGqYTO6yTQ7VT7EHsHKSmIWXyQS3hItAZ0U4AbOX7-UBNZyZK5QfcJY7nM_OecYc8n6YmuxgndhXgyicLgRlVOJ1w&_hsmi=438339194&utm_content=438339194&utm_source=hs_email
Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon The success of the company’s lung disease drug in a mid-stage study is a testament to its approach
https://www.statnews.com/2026/09/10/roivant-biotech-dealmaking-mosliciguat-origins/
By Adam FeuersteinSept. 10, 2026
Senior Writer, Biotech
Cancer medicines remain in short supply across the U.S., survey finds More than 20% of all cancer centers report shortages of five or more different medicines
https://www.statnews.com/pharmalot/2026/09/10/cancer-medicines-remain-in-short-supply-across-the-united-states/
By Ed SilvermanSept. 10, 2026
Pharmalot Columnist, Senior Writer
John Fetterman’s post-stroke, politically problematic behaviors offer lessons about brain health on Capitol Hill One politician’s ‘laziness’ is another patient’s ‘apathy’
https://www.statnews.com/2026/09/10/john-fetterman-post-stroke-behavior-experts-see-neurological-changes/
By Michael P.H. Stanley and Isaiah KletenikSept. 10, 2026
Stanley is a cognitive neurologist in Boston. Kletenik is a behavioral neurologist in Boston.
Five midterm races to watch that could be crucial for vaccine policy The Trump administration wants to give states more latitude, and some candidates are running with it
https://www.statnews.com/2026/09/10/2026-midterms-health-care-issues-analyzed-vaccine-policy/
By Chelsea CirruzzoSept. 10, 2026
Washington Correspondent
Trump officials say AI will help save rural health care. Some leaders in the field don’t believe it Health systems want to invest in AI, but Medicaid cuts are undermining their budgets By Daniel PayneSept. 10, 2026
Trump officials say AI will help save rural health care. Some leaders in the field don’t believe it
Health systems want to invest in AI, but Medicaid cuts are undermining their budgets
By Daniel PayneSept. 10, 2026
Payne traveled to Maine and Louisiana to report on rural health systems and interviewed health AI experts and vendors for this story. It is the fourth installment in STAT’s Unraveled series, which explores the consequences of President Trump’s unprecedented cuts to the health care safety net.
https://www.statnews.com/2026/09/10/rural-health-care-ai-adoption-challenges-part-4-unraveled-series/
Suscribirse a:
Entradas (Atom)
